Starling Oncology, Inc. Realized Investment Gains (Losses)
Starling Oncology, Inc. (DFPH) reported Realized Investment Gains (Losses) of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2024-11-13
- Starling Oncology, Inc. realized investment gains (losses) for the quarter ending 2024-09-30 was $0.00.
- Starling Oncology, Inc. realized investment gains (losses) for the quarter ending 2023-09-30 was $0.00.
- Starling Oncology, Inc. realized investment gains (losses) for the quarter ending 2022-09-30 was $0.00.
| Period end | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 6 month | Realized Investment Gains (Losses) 9 month |
|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$11.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | -$11.00K 10-Q · filed 2024-08-13 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 |